Wouter J. Plattel

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

Marie José Kersten, Julia Driessen, Josée M. Zijlstra et al. · Haematologica · 2020 · 92 citations · Full text

Immunology, Pathology, Primary Refractory +17

Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients

Simone de Vries, Michael Schaapveld, Cécile P.M. Janus et al. · JNCI Journal of the National Cancer Institute · 2020 · 90 citations · Full text

Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma

Wouter J. Plattel, Anke van den Berg, Leo H. Visser et al. · Haematologica · 2011 · 68 citations · Full text

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study

Mirian Brink, Frederik O. Meeuwes, Marjolein van der Poel et al. · Blood · 2022 · 66 citations · Full text

Asct Consolidation, Aging, Disease Progression +27

Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of <scp>sG</scp>alectin‐1, <scp>sCD</scp>163 and <scp>sCD</scp>30 with TARC

Wouter J. Plattel, Zainab N. D. Alsada, Gustaaf W. van Imhoff et al. · British Journal of Haematology · 2016 · 47 citations · Full text

Immunodeficiencies, Immunology, Pathology +18